Spectral Md, Inc. — Department of Defense STTR Phase I: DHA17A-006
Spectral Md, Inc. — STTR Phase I award from Department of Defense.
- Amount
- $149,828
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- STTR · Phase I
- Topic
- DHA17A-006
- Solicitation
- 2017.0
- NAICS
- —
- Place of performance
- TX
- Period
- 2017-09-15 → 2018-04-14
Description
The primary objective of this proposal is to design and demonstrate the SpectralMD DeepView imaging technology can allow surgeons to quickly and objectively assess the viability of tissue in a burn excision site prior to skin grafting. DeepView uses machine learning algorithms to analyze data acquired by multispectral imaging to generate quantitative prognostic images with a user-friendly output that is easily interpretable. It is to our knowledge the only burn imaging technology that has undergone thorough investigation in a pre-clinical animal model of burn excision, where it demonstrated success in detecting tissue viability throughout the skin layers and into the subcutaneous fat. Upon completion of this project, a portable DeepView system will be designed that provides images of the post-excisional remaining tissues in real-time to aid surgeons in determining if and how much burn tissue to excise. Other uses of the portable DeepView device include: diagnosing burn wound healing potential and the need for surgery during in burn triage; determining proper level of limb amputation to minimize the high rate of re-amputation in the chronic wound population; and monitoring of reconstructive flap viability. The portable DeepView system will have wide commercial utility in addition to the current military-focused application.